Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

BACKGROUND: The development of a more refined prognostic methodology for early non-small cell lung cancer (NSCLC) is an unmet clinical need. An accurate prognostic tool might help to select patients at early stages for adjuvant therapies. RESULTS: A new integrated bioinformatics searching strategy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Aramburu, Ander, Zudaire, Isabel, Pajares, María J., Agorreta, Jackeline, Orta, Alberto, Lozano, María D., Gúrpide, Alfonso, Gómez-Román, Javier, Martinez-Climent, Jose A., Jassem, Jacek, Skrzypski, Marcin, Suraokar, Milind, Behrens, Carmen, Wistuba, Ignacio I., Pio, Ruben, Rubio, Angel, Montuenga, Luis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595201/
https://www.ncbi.nlm.nih.gov/pubmed/26444668
http://dx.doi.org/10.1186/s12864-015-1935-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595201/
https://www.ncbi.nlm.nih.gov/pubmed/26444668
http://dx.doi.org/10.1186/s12864-015-1935-0

Ejemplares similares